<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-09T03:34:31Z</responseDate>
  <request metadataPrefix="oai_dc" verb="GetRecord" identifier="oai:jair.repo.nii.ac.jp:02001548">https://jair.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:jair.repo.nii.ac.jp:02001548</identifier>
        <datestamp>2025-01-24T06:29:57Z</datestamp>
        <setSpec>1616224532673:1708403533383:1709527606303:1709528286510</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>(ナテグリニドの効果不十分例におけるビルダグリプチンへの切り替えおよび併用の効果と安全性の比較検討)</dc:title>
          <dc:title>Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide</dc:title>
          <dc:creator>藤巻, 杏子</dc:creator>
          <dc:creator>フジマキ, キョウコ</dc:creator>
          <dc:description>順天堂大学</dc:description>
          <dc:description>博士（医学）</dc:description>
          <dc:description>2013年度</dc:description>
          <dc:description>doctoral thesis</dc:description>
          <dc:date>2014-03-20</dc:date>
          <dc:type>AM</dc:type>
          <dc:format>application/pdf</dc:format>
          <dc:format>application/pdf</dc:format>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>甲第1485号</dc:identifier>
          <dc:identifier>https://jair.repo.nii.ac.jp/record/2001548/files/MDK1485-sinyou.pdf</dc:identifier>
          <dc:identifier>https://jair.repo.nii.ac.jp/record/2001548/files/MDK1485-ronyou.pdf</dc:identifier>
          <dc:identifier>https://jair.repo.nii.ac.jp/record/2001548/files/MDK1485-zenbun.pdf</dc:identifier>
          <dc:identifier>https://jair.repo.nii.ac.jp/records/2001548</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:relation>https://doi.org/10.1111/jdi.12160</dc:relation>
          <dc:rights>This is the peer reviewed version of the following article:[Kudo-Fujimaki K, Hirose T, Yoshihara T, Sato F, Someya Y, Ohmura C, Kanazawa A, Fujitani Y, Watada H. Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. J Diabetes Investig. 2014 Jul;5(4):400-9. ], which has been published in final form at [http://onlinelibrary.wiley.com/doi/10.1111/jdi.12160/full].</dc:rights>
          <dc:rights>open access</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
